chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient developed intense pruritus over whole body. Few, diffuse hives noted on arm, back, neck. Redness and slight inflammation at sites where vaccines were given due to presence of bandaids. Patient developed these symptoms less than 24 hrs. of receiving the above listed vaccines. Patient stated that she did not have any adverse reaction to the first doses of these vaccines, nor has she ever had a reaction to a vaccine in the past. Patient has a stated allergy to sulfa drugs. Patient elected to see a physician today. She directly left Health office to be seen at clinic.
Had flushing and warm   BP elevated to 158/98 pulse 68 for 30 min and resolved on own
Information has been received from a physician referring to an unspecified number of patients of unknown age and gender. The patients' concurrent condition, medical history and concomitant therapy were not reported. On an unknown date, the patients were vaccinated with improperly stored vaccine RECOMBIVAX HB (dose, strength and frequency unknown) that underwent temperature excursion every day since May 2017. She also reported that the vaccines may also have had temperature excursions prior to May 2017. For RECOMBIVAX HB lot numbers are N006321 expiration 08-NOV-2019, M037248 expiration 21-FEB-2019. The vaccine was stored at 32 to 35 degrees Fahrenheit for 25 hours and 47 to 77 degrees Fahrenheit for 55 hours. There had not been a previous temperature excursion and the phone call was a result of the data logger.  No adverse effects were reported. This is one of the several reports from the same reporter. This report has been linked to reports 1707USA002962, 1708USA004862 and 1708USA004861. .; Sender's Comments: US-009507513-1707USA002962: US-009507513-1708USA004861: US-009507513-1708USA004862:
Information has been received from a pharmacist via a field representative referring to a 77 year old female patient. There was no medical history or drug reaction/allergies reported. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot# were unknown) and an unspecified high dose influenza vaccine (dose, route and lot# were unknown) at her unspecified physician's office. Concomitant therapies included ZOCOR, NORVASC and SYNTHROID. On an unspecified date after the vaccinations, the patient became tired and reported difficulty walking due to her limbs becoming painful and stiff (unspecified how many limbs involved). The patient was seen by her unspecified physician on an unspecified date related to her symptoms, however, it was unspecified what the diagnosis or treatment was. The outcome of the events was unknown. The reporter considered the event "difficulty walking" was disability. Additional information has been requested.
Narrative: About 2 hours after receiving Moderna booster (#2) on 4/22/2022, employee states "my throat started feeling like it was hard to swallow and swollen, down into my bronchus. In this instance, my BP remained in its usual range and I look 100 mg Benadryl PO Friday afternoon and a nebulizer treatment at home and 50 mg on Saturday. I have notified my regular doctor."
I have been diagnosed with psychosis ever since I had the vaccine. I never had it before receiving the vaccine. I had went to the Hospital in either August or September of 2021. The doctors prescribed me with an antipsychotic and an Abilify shot.
Pain in shot area.  Never got better.  I am going to Physical Therapy now because I was having pain and could not lift my right arm.
Information has been received from a medical assistant concerning a 16 year old female who in April 2008, was vaccinated with a first dose of GARDASIL vaccine (yeast). No adverse reaction was reported. In July 2008, the patient was vaccinated with a second dose of GARDASIL vaccine (yeast) (lot #660620/0571X). In July 2008, after the vaccination, the patient "held her head and fainted". Medical attention was sought, the patient spoke to medical assistant. At the time of this report, the outcome was unknown. Additional information has been requested.
pt states exp a sore lt arm, body aches, sl h/a, changes in heart beat (describes as sl painful & fluttering) & cramps in stomach p/eating since recv vax 8OCT96 sx began 10OCT96;
The muscles above knee have swollen larger than  knees; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 04Apr2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included RA (rheumatoid arthritis) and fibromyalgia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included folic acid (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and hydroxychloroquine (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 07Apr2021, the patient experienced muscles above knee had swollen larger than knees. She was taken off methotrexate two weeks prior to the first vaccination and was going to resume two weeks after most recent vaccination. This had not happened in previous flare-ups. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported event. The clinical outcome of event the muscles above knee had swollen larger than knees was not recovered at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 22Apr2021 at 13:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
covid 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid 19) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Patient had received primary series and booster.She didn't get COVID right after the shot,She got COVID in September.                                   No treatment information was provided by the reporter.
I experienced chest tightness and numbness (trigeminal myalgia). I had heart palpitations (blood pressure went up and heart resting rate was high as well). I scheduled a virtual appointment with my doctor for the following week since I could not reach her initially while I was at my campsite. She referred me for Thyroid testing. I was referred to a Endocrinologist who did not feel that my Thyroid function was off enough to put me on medication and she referred me to a Surgeon because I have a Thyroid Nodule just to rule out that it's not my Thyroid.; however because of my chest tightness did repeat tests for a month Heart rate and blood pressure are still off and my normal doctor put me on metoprolol to take every day. I was also prescribe gabapentin to take whenever I have numbness and nerve pain.
Fever, headache , chills they lasted 1 day.  Totally recovered the second day.
Went in for Moderna booster.  Asked pharmacist if I was getting the half dose (.25ml) and she said no, that Moderna booster was full dose.  The paperwork I received says 0.5.  Went home and researched and she was wrong.
Patient developed a red, warm to touch arm, slightly tender. He states he was flushed over the weekend, but did not take temp. Dr advised 50mg BENADRYL and cold packs.
3pm 3/12/14 - HA tx - ADVIL. Evening 3/12/14 - pain at injection site, redness at injection site, nausea, (R) sided neck pain, body myalgias, chills, fever as high as 102.6 tx - ADVIL, dizziness, irregular breathing. 10am 3/13/14 - fever 100.4, soreness and redness at inj. site tx - ADVIL.
Received ZOSTAVAX 5/26/10, Wed. On Fri, 5/28/10, Developed small red pimples in public area. Over few days spread to upper abdomen: Down thighs. Went to clinic, rec'd Acyclovir, Ciptzofloxacin, Clotizimazol/Betamethasone Cream. No diagnosis An red blistering, Lgr than chickenpox, bleeding; oozing SSF. Extreme pain, dull, continuous. Nurse Pract started silvadene yesterday 6-7-10. No relief.
Pt was feeling flushed. Reports a history of hypertension and anxiety.  Blood pressure 163/93, reduced ten min later to 156/90. Pt reports not having taken BP medication yet today.
It start with sinus pressure, fever, brain fog, congestive, and fatigue. I also have dizziness. These symptoms are still ongoing as of today Jan 28th. I was tested positive for Covid-19 on Jan 22nd.
41 y.o. female presents to the ED with concern for possible allergic reaction to Moderna COVID-19 vaccine that she had received approximately an hour prior to arrival.  Patient reports that shortly after receiving her vaccine in her left arm she developed the sensation of her throat closing and a "film "in the back of her throat.  Patient has also reported feeling nauseated and having a throat clearing cough.  No chest pain, headache, abdominal pain or development of a rash.  Injection site appears to be unremarkable. Patient is given some antihistamine medications as well as steroids and observed here in the ED.  The patient has improvement in her sensation of her throat closing and is able to be discharged.  I discussed with the patient the usefulness of continued antihistamines over the course of the next few days and would likely advise on not receiving the second COVID-19 vaccine based on her reaction to the first.  Discussed with the patient the use of epinephrine and EpiPen as needed.  See discharge instructions.  Patient is discharged home with her sister in improved condition.
Dull pain in inner ear- Patient thought it felt like an ear infection (pressure). lasted 24 hours.
the patient received her 1st and 2nd dose of IPOL 1 month apart as recommend and that the 3rd dose is due 6 months following the 2nd dose; Initial information received on 26-Jun-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a patient of unknown demography who received vaccine IPV (VERO) [IPOL] and reported that the patient received her 1st and 2nd dose of Ipol 1 month apart as recommend and that the 3rd dose is due 6 months following the 2nd dose.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 25-Jun-2019, the patient received a 3rd dose of suspect IPV (VERO) lot number not reported via unknown route in unknown administration site. 2 other doses were administered on unknown dates for suspect IPV (VERO).  It was a case of actual medication error due to inappropriate schedule of vaccine administered.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
aching and swelling for no; aching and swelling for no; elbow allograft fractured; shoulders were very sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Mar2021 (Lot number: EN6208) at the age of 62 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "L shoulder repair", start date: 1985 (unspecified if ongoing); "R shoulder repair", start date: 1998 (unspecified if ongoing); "tumor removed", start date: 1985 (unspecified if ongoing), notes: Background - In 1985 I had synovial, sarcoma soft tissue tumor removed, from right elbow followed by radiation.; "radiation", start date: 1985 (unspecified if ongoing), notes: Background - In 1985 I had synovial, sarcoma soft tissue tumor removed, from right elbow followed by radiation.; "synovial sarcoma soft tissue tumor" (unspecified if ongoing), notes: Background - In 1985 I had synovial, sarcoma soft tissue tumor removed, from right elbow followed by radiation.; "right medial epicondyle", start date: Mar2017 (unspecified if ongoing), notes: March 2017, I had a second tumor, removed from right medial epicondyle. Concomitant medication(s) included: AMLODIPINE BESYLATE; FAMOTIDINE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6203, Location of injection: Arm Left), administration date: 26Feb2021, when the patient was 62 years old, for Covid-19 immunization. The following information was reported: ARTHRALGIA (disability) with onset Jul2021, outcome "not recovered", described as "shoulders were very sore"; UPPER LIMB FRACTURE (disability) with onset Jul2021, outcome "not recovered", described as "elbow allograft fractured"; PAIN IN EXTREMITY (disability), JOINT SWELLING (disability), outcome "not recovered" and all described as "aching and swelling for no". The events "shoulders were very sore", "elbow allograft fractured", "aching and swelling for no" and "aching and swelling for no" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Jan2022) negative, notes: Nasal swab. Therapeutic measures were taken as a result of arthralgia, upper limb fracture, pain in extremity, joint swelling.  Clinical course: Facility type Vaccine was Pharmacy or Drug Store. No other vaccine in four weeks. No covid prior vaccination and covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Pt called doctor's office today. C/o "trouble breathing & wheezing on day of injections, that evening. Feels better today.
Diluent without the lyophilized powder; Diluent only administered; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 87-year-old female patient who received Herpes zoster (Shingrix) (batch number MK9Y2, expiry date 1st July 2023) for prophylaxis.   On 20th September 2022, the patient received Shingrix. On 20th September 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.    Additional Information: GSK Receipt Date: 22-SEP-2022 Reporter's Comments: The pharmacist called to inquire about any information. The nurse administered the Shingrix diluent without the lyophilized powder component to a patient. The reporter did not consent to follow up. Additional Supportive Information: The patients received Shingrix vaccines without the lyophilized powder component which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Small red bumps on her trunk and left arm. She also has poison ivy so received (prednisone) for treating that.
suffered about 1 1/2 hrs of chills, muscular convuls (moderate) in all limbs & torso (stomach area); this occurred @ 3AM the noc p/flu shot; no temperature taken; no recurring sx;
10 hours after my shot I had moderate to severe chills with pains that moved around my body. Pain would go from deep pain in my leg, to hands, to feet.  Not ache like the flu, but piercing pain.  Head ache as well. This first round lasted for 1 hour and 36 minutes.  Then, a break for almost two hours. Following that break, the next 12 hours i was achy throughout my body, headache that would come and go and very fatigued.  I was only able to get out of bed for roughly 2 hours during that 12 hour stretch. Following this I ended up getting a fever later that night that lasted for about 2 hours (100.5 at the highest).    Since that night I have had pain daily throughout my body.  They are quick, sometime sharp pains in my head, and various muscles throughout my body. I have also had deep pains as well that have come and go in random muscles in my body.
pt recieved vaccine on 8/24/09. Pt started c/o of itching, reddness and swelling at injection site on 8/25/09. 18X12cm wheel noted to left posterior arm. Dr examined pt and no systemic events occured. Dr prescribed benadryl 25mg q 6 hr prn and hydrocortisone cream 2.5%.
Patient received vaccine and within 1/2 hour a 1 1/2 red streak appeared on her arm. Within an hour the red marks had expanded to over half her arm down her deltoid down the medial antebrachial section of her arm. She was taken to the emergency department for further evaluation.
Noticeable fluttering heart beat, stronger than normal, causes a tightness and some pain in the chest. Occurs on and off all through out the day, every day
Bilateral knee swelling (anterior and posterior), pain in arm where injection occurred, chest pain. Symptoms are slowly worsening.
Information has been received from a licensed practical  nurse concerning a 12 month old white female with no allergies or medical history who on24 Jan 2006 was vaccinated SC with a 0.5 mL first dose of Variavax (lot #648314/0071R). Concomitant vaccination on the same day included a fourth IM dose of ActHib (lot # UE774AA). There was no illness at the time of vaccination. On 07 Feb 2006, the patient was seen in the physician's office with inflammation at the injection site. She was started on Ceftin (125/5 6 mL BID x 10 days). The patient's outcome was unknown. A product quality complaint was not involved. Additional information is not expected. s
The week of the vaccine, I was super tired, and it would not get better. It took about ten days for me to get back to normal, I was very week and felt like I was being hit by something big. This is the first time that it took me that long to recover, normally after a vaccine shot I can bounce back in about three days or so but not this time. It took like ten days to recover. On August 26th I went to the Dr. for a severe sore throat and runny nose and was very fatigued, I thought I had COVID-19 and I went to get tested but it was negative. On November 3rd I went back to the DR. I was still having the same issues with my sinuses and he put me on a steroid, and on 11/14/2022, I went back and I was congested in my chest and sinuses and I had bad headaches, and the Dr. put me on antibiotics and antihistamine as well. I still have congestion and it has not full gone away. I take a saline mist called AFRIN to help with my sinuses and this has been going on since August and it has not stopped yet. I also meant to say that on the first day of the vaccine I also got a rash but it was not because of the COVID-19 vaccine but because I got the FLU vaccine at the same time.
After shower, noticed raised, red, hot, itchy tennis ball diameter size bump around area of vaccine   Area  on 2/8 measured 10cm wide x 9cm long per doctor office visit. Starting to make shoulder and elbow joints ache. Area still very warm to touch, raised, red, and itchy. Area of redness and swelling moved up the arm towed shoulder more
General aching all over 2 days. Splotchy areas L arm above elbow.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a patient who experienced rash and hives. The patient received a dose on an unspecified date and a dose on an unspecified date. On an unspecified date, the patient experienced rash and hives. The patient visited a physician. Treatment was not reported. The patient's outcome was unknown. See related case(s): US-WYE-H15155310 (adverse event, non-expedited) and US-WYE-H15212810 (adverse event, non-expedited). No additional information was available at the time of this report.
cold; no energy at all; chills; fever of 99 degrees Celsius; achy; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), ASTHENIA (no energy at all), CHILLS (chills), PYREXIA (fever of 99 degrees Celsius) and MYALGIA (achy) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 030L20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3, VITAMIN C [ASCORBIC ACID], ZINC, PROBIOTICS NOS, MONTELUKAST SODIUM (SINGULAIR), CETIRIZINE HYDROCHLORIDE (ZYRTECNO), METOPROLOL SUCCINATE (TOPROL), PRAVASTATIN SODIUM (PRAVASTINE), CALCIUM, ACETYLSALICYLIC ACID (ASPIRIN LOW), CLOPIDOGREL BISULFATE (PLAVIX) and LANSOPRAZOLE (PREVACID) for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), ASTHENIA (no energy at all), CHILLS (chills), PYREXIA (fever of 99 degrees Celsius) and MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold), ASTHENIA (no energy at all), CHILLS (chills), PYREXIA (fever of 99 degrees Celsius) and MYALGIA (achy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 99 (High) 99 degree F.         Action taken with mRNA-1273 in response to the events was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-051556 (Patient Link).
I think this was my fifth shot.  I have strong pain in my right arm.  The biggest issue has been severe, sharp shooting pains in my neck and head that lasted the whole first night after the shot and less frequently the next day (it lessened after Tylenol).  Now on the third day I have body aching all over, neuropathy and nausea, and I've had a headache since the first night.  I have had similar reactions every time I have gotten the vaccine, but this has been one of the worst.  It's so bad I'm not sure I can get another one in the future and I'm also scared now of getting the flu shot.  (I am in no way anti-vax, just having a really hard time with this).  I haven't spoken with doctor yet but am planning to on next appointment.
Redness, hot to touch at injection site. Given Benadryl and Orapred x 5 days.
Approx 3 minutes s/p 1st vaccination, pt c/o hotness and  Pruritis to R forehead.  `1 urticaria noticed (the size of a quarter) redness and itching present at site. Pt denies shortness of breath, chest discomfort, heaviness of the tongue, or swelling of the throat.  Upon exam VSS SBP/ 134/90 HR 58 R 18 O2 99% on R T 98.1, Uvula midline, no wheezing heard, no swelling of the tongue or lips noted, pt does not have urticaria present anywhere else on body, PE benign.  Secondary, to history of allergies (seasonal and shrimp) for which he is under the care of an allergist, Benadryl 50mg po was adminstered at 10:11, with resolution of urticaria 10:41